November 8, 2014
Notes: Ganeva, Maria
Research Support, Non-U.S. Gov’t
Adv Clin Exp Med. 2013 Jul-Aug;22(4):555-63.
Author Address: Section of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Thracian University, Stara Zagora, Bulgaria.
Reference Type: Journal Article
Record Number: 4564Author: Gee, S. N., Zakhary, L., Keuthen, N., Kroshinsky, D. and Kimball, A. B.
Title: A survey assessment of the recognition and treatment of psychocutaneous disorders in the outpatient dermatology setting: how prepared are we?
Journal: J Am Acad Dermatol
Short Title: A survey assessment of the recognition and treatment of psychocutaneous disorders in the outpatient dermatology setting: how prepared are we?
Alternate Journal: Journal of the American Academy of Dermatology
ISSN: 1097-6787 (Electronic)
Accession Number: 22954748
Keywords: Clinical Competence
Mental Disorders/complications/diagnosis/*drug therapy
*Physician’s Practice Patterns
Psychotropic Drugs/therapeutic use
Abstract: BACKGROUND: Dermatologists provide the bulk of psychocutaneous care; however, recent studies suggest that dermatologists believe they are largely underprepared to treat most psychocutaneous conditions. OBJECTIVE: We sought to identify gaps in psychodermatologic knowledge among practicing dermatologists in two academic institutions. METHODS: An online survey was sent to 59 dermatologists at the Massachusetts General Hospital (Boston, MA) and Brigham and Women’s Hospital (Boston, MA) from July 2010 through October 2011. RESULTS: The response rate was 40 of 59 (68%). More than 50% of dermatologists were comfortable making diagnoses for 8 of 10 psychocutaneous disorders. In all, 57% were comfortable making a diagnosis of depression. A total of 11% were comfortable starting antidepressants; 3%, antipsychotics; and 66%, medications for neuropathic pain. In all, 72%, 68%, and 21% of dermatologists never prescribe antidepressants, antipsychotics, or medications for neuropathic pain, respectively. Only 38% believed they were successful treating compulsive skin picking; 15%, body dysmorphic disorder; 27%, delusions of parasitosis; and 24%, depression. LIMITATIONS: Limitations include small sample size, data extraction from an academic setting, self-reporting of outcome measures, and response bias. CONCLUSION: Although the majority of the physicians surveyed believed they were capable of diagnosing psychocutaneous disease, very few were comfortable starting psychotropics or thought they were successful treating such conditions.